PREDICTION AND PREVENTION OF THROMBOEMBOLIC EVENTS WITH ENOXAPARIN IN CANCER PATIENTS WITH ELEVATED TISSUE FACTOR-BEARING MICROPARTICLES: A RANDOMIZED-CONTROLLED PHASE II TRIAL (THE MICROTEC STUDY)

Elevated levels of circulating tissue factor-bearing microparticles (TFMP) have been associated with an increased risk of developing venous thromboembolism (VTE) in cancer patients. We performed a randomized phase II study to evaluate the cumulative incidence of VTE in advanced cancer patients with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zwicker, JI, Liebman, HA, Bauer, KA, Caughey, T, Campigotto, F, Rosovsky, R, Mantha, S, Kessler, CM, Eneman, J, Raghavan, V, Lenz, HJ, Bullock, A, Buchbinder, B, Neuberg, D, Furie, B
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3609903/
https://ncbi.nlm.nih.gov/pubmed/23240761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12163
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados